Objective: To evaluate 2 heel lancet devices in terms of pain response and success of the procedure in neonates undergoing the newborn screening test.Design: Randomized trial.Setting: Tenth level, mother-and-baby unit of a university-affiliated hospital.
Patients: Eighty term neonates.Interventions: Heel lance using either the BD SafetyFlow lancet (SF) or the BD QuikHeel lancet (QH).
Main Outcome Measures:Facial grimacing score (brow bulge, eye squeezed shut, and nasolabial furrow [range, 0%-100%]), cry duration, duration of the procedure, and number of punctures required to collect the blood.Results: Forty neonates were enrolled in each group. There were no differences in the demographic characteristics between groups. During the first skin puncture, the median score (25th-75th percentile) for facial grimacing was 100% (76%-100%) for the SF compared with 73% (42%-100%) for the QH (P=.02). For cry duration, it was 6 seconds (0-9 seconds) vs 0 seconds (0-6 seconds), respectively (P=.01). Pain scores during blood collection (ie, squeezing) did not differ between groups (P=.09). The procedure took less time to perform in the QH group (140 seconds
Conclusion:The BD QuikHeel lancet is superior to the BD Safety-Flow lancet for blood collection in term neonates undergoing the newborn screening test.